XML 54 R39.htm IDEA: XBRL DOCUMENT v3.22.1
EARNINGS PER SHARE (Tables)
12 Months Ended
Jan. 30, 2022
Earnings Per Share [Abstract]  
Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]

We expect to continue to grant these types of awards annually in the future. The following table sets forth the number of outstanding restricted stock awards and RSUs and PSUs, net of forfeitures and vested shares, as of the fiscal period-end dates indicated:

 

   

January 30,

   

January 31,

   

February 2,

 
   

2022

   

2021

   

2020

 
                         

Restricted shares

    59,500       54,747       45,946  

RSUs and PSUs

    77,841       140,911       73,060  
      137,341       195,658       119,006  

 

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] The following table sets forth the computation of basic and diluted earnings per share:
   

Fifty-Two Weeks Ended

 
   

January 30,

   

January 31,

   

February 2,

 
   

2022

   

2021

   

2020

 
                         

Net income/(loss)

  $ 11,718     $ (10,426 )   $ 17,083  

   Less: Dividends on unvested restricted shares

    46       36       25  

             Net earnings allocated to unvested restricted stock

    61       -       60  

Earnings available for common shareholders

  $ 11,611     $ (10,462 )   $ 16,998  
                         

Weighted average shares outstanding for basic

                       

   earnings per share

    11,852       11,822       11,784  

Dilutive effect of unvested restricted stock awards

    118       *       54  

   Weighted average shares outstanding for diluted

                       

      earnings per share

    11,970       11,822       11,838  
                         

Basic earnings/(loss) per share

  $ 0.99     $ (0.88 )   $ 1.44  
                         

Diluted earnings/(loss) per share

  $ 0.97     $ (0.88 )   $ 1.44  

 

*Due to the fiscal 2021 net loss, approximately 119,000 shares would have been antidilutive and are therefore excluded from the calculation of earnings per share.